Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 0.000p
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: 0.000p
  • 52 Week Low: 0.000p
  • Currency: UK Pounds
  • Shares Issued: 84.90m
  • Volume: 0
  • RiskGrade: 196

Latest Deals

Traded Action Notifier PriceAmountValue
01-Oct-25 Transfer From Nick Roberts 0.000p 91 £0.00
01-Oct-25 Buy Nick Roberts 165.00p 91 £150.15
13-May-25 Sell Peter Keeling 126.00p 500,000 £630,000.00
28-Apr-25 Transfer From Nick Roberts 0.000p 126 £0.00
28-Apr-25 Buy Nick Roberts 118.80p 126 £149.69

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
13-May-25 Sell Peter Keeling 126.00p 500,000 £630,000.00
30-Jan-25 Buy Graham Paterson 137.50p 11,643 £16,009.13
01-Oct-25 Buy Nick Roberts 165.00p 91 £150.15
01-Apr-25 Buy Nick Roberts 120.10p 125 £150.13
28-Jan-25 Buy Jordan Clark 144.00p 104 £149.76

Director Shareholdings

Notifier Holding Value*
Peter Keeling 15,252,049 £0
Ryan Gerard Keeling 2,990,643 £0
Graham Paterson 85,141 £0
Nick Roberts 65,418 £0
Richard Charles Hindson 63,500 £0
Jordan Clark 424 £0

Major Shareholders

Notifier** Holding Value*
Gresham House Asset Management Ltd 14,435,250 £0
Gresham House 13,243,500 £0
Canaccord Genuity 8,167,000 £0
Berenberg Asset Management 5,069,500 £0
Universal-Investment-Gesellschaft mbH 4,009,764 £0
Danske Bank A/S 3,379,766 £0
Elizabeth Considine 3,112,169 £0
Herald Investment Management 3,011,000 £0
BlackRock Investment Mgt 2,714,165 £0
West Elk Capital, LLC 2,543,281 £0
SLP Innovations Ltd 2,446,327 £0
Octopus Investments 2,420,500 £0

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 164.00p
Closing Price Change 0.000p
% Change 0.00 %
52 Week High 0.000p
52 Week Low 0.000p
Volume 0
Shares Issued 84.90m
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
33.57% below the market average33.57% below the market average33.57% below the market average33.57% below the market average33.57% below the market average
51.52% below the sector average51.52% below the sector average51.52% below the sector average51.52% below the sector average51.52% below the sector average
Price Trend
29.40% above the market average29.40% above the market average29.40% above the market average29.40% above the market average29.40% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Income Not Available
Growth
48.02% above the market average48.02% above the market average48.02% above the market average48.02% above the market average48.02% above the market average
54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average

Diaceutics Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page